Annexin Pharmaceuticals AB (publ) - ESG Rating & Company Profile powered by AI
Scroll down to the end of the page for potential risks for Annexin Pharmaceuticals AB (publ) based on sector, geography and marketcap. Detailed ESG analysis of Annexin Pharmaceuticals AB (publ) can be accessed by registering for free. This webpage displays a zero-cost E,S&G analysis for Annexin Pharmaceuticals AB (publ).
Annexin Pharmaceuticals AB (publ) in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.8; made up of an environmental score of 0.0, social score of 2.7 and governance score of 2.7.
1.8
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1617 | Berry Genomics Co Ltd | 1.9 | Low |
1617 | scPharmaceuticals Inc | 1.9 | Low |
1631 | Annexin Pharmaceuticals AB (publ) | 1.8 | Low |
1631 | Cannabis Global, Inc. | 1.8 | Low |
1631 | Cannabis Strategic Ventures | 1.8 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Annexin Pharmaceuticals AB (publ) have an accelerator or VC vehicle to help deliver innovation?
Does Annexin Pharmaceuticals AB (publ) disclose current and historical energy intensity?
Does Annexin Pharmaceuticals AB (publ) report the average age of the workforce?
Does Annexin Pharmaceuticals AB (publ) reference operational or capital allocation in relation to climate change?
Does Annexin Pharmaceuticals AB (publ) disclose its ethnicity pay gap?
Does Annexin Pharmaceuticals AB (publ) disclose cybersecurity risks?
Does Annexin Pharmaceuticals AB (publ) offer flexible work?
Does Annexin Pharmaceuticals AB (publ) have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Annexin Pharmaceuticals AB (publ) disclose the number of employees in R&D functions?
Does Annexin Pharmaceuticals AB (publ) conduct supply chain audits?
Does Annexin Pharmaceuticals AB (publ) disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Annexin Pharmaceuticals AB (publ) conduct 360 degree staff reviews?
Does Annexin Pharmaceuticals AB (publ) disclose the individual responsible for D&I?
Does Annexin Pharmaceuticals AB (publ) disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Annexin Pharmaceuticals AB (publ) disclose current and / or historical scope 2 emissions?
Does Annexin Pharmaceuticals AB (publ) disclose water use targets?
Does Annexin Pharmaceuticals AB (publ) have careers partnerships with academic institutions?
Did Annexin Pharmaceuticals AB (publ) have a product recall in the last two years?
Does Annexin Pharmaceuticals AB (publ) disclose incidents of discrimination?
Does Annexin Pharmaceuticals AB (publ) allow for Work Councils/Collective Agreements to be formed?
Has Annexin Pharmaceuticals AB (publ) issued a profit warning in the past 24 months?
Does Annexin Pharmaceuticals AB (publ) disclose parental leave metrics?
Does Annexin Pharmaceuticals AB (publ) disclose climate scenario or pathway analysis?
Does Annexin Pharmaceuticals AB (publ) disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Annexin Pharmaceuticals AB (publ) disclose the pay ratio of women to men?
Does Annexin Pharmaceuticals AB (publ) support suppliers with sustainability related research and development?
Does Annexin Pharmaceuticals AB (publ) disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Annexin Pharmaceuticals AB (publ) reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Annexin Pharmaceuticals AB (publ) involved in embryonic stem cell research?
Does Annexin Pharmaceuticals AB (publ) disclose GHG and Air Emissions intensity?
Does Annexin Pharmaceuticals AB (publ) disclose its waste policy?
Does Annexin Pharmaceuticals AB (publ) report according to TCFD requirements?
Does Annexin Pharmaceuticals AB (publ) disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Annexin Pharmaceuticals AB (publ) disclose energy use targets?
Does Annexin Pharmaceuticals AB (publ) disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Annexin Pharmaceuticals AB (publ) have a policy relating to cyber security?
Have a different question?
Potential Risks for Annexin Pharmaceuticals AB (publ)
These potential risks are based on the size, segment and geographies of the company.
Annexin Pharmaceuticals AB (publ), a biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases. The company develops ANXV, a human recombinant protein. It offers Annexin A5 to protect and repair blood vessels and counteract inflammation. The company was founded in 2014 and is based in Stockholm, Sweden.